Methotrexate treatment for advanced bladder cancer.
D000368:Aged; D001772:Blood Cell Count; D002295:Carcinoma, Transitional Cell / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D003404:Creatinine / Q000097:blood; D003967:Diarrhea / Q000139:chemically induced; D006801:Humans; D007677:Kidney Function Tests; D007680:Kidney Neoplasms / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008207:Lymphatic Metastasis; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D014508:Urea / Q000097:blood; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D014567:Urography; D014839:Vomiting / Q000139:chemically induced
D014508:Urea; D003404:Creatinine; D008727:Methotrexate